Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 693-699

  Tannenbaum, Charles S ^a   Wicker, Nancy ^a   Armstrong, David ^a   Tubbs, Raymond ^a   Finke, James ^a   Bukowski, Ronald M ^a   Hamilton, Thomas A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANZYME B; HYDROLASE; MESSENGER RNA; PERFORIN; RECOMBINANT ALPHA INTERFERON AD; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOLYSIS; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION;

ADENOCARCINOMA; ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CARCINOMA, RENAL CELL; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; COLONIC NEOPLASMS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANZYMES; INTERFERON TYPE II; INTERLEUKIN-12; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGE-1 ANTIGEN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MONOCYTES; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030070446     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sayers, T. J., T A. Wiltrout, K. McCormick, C. Husted, and R. H Wiltrout. 1990. Antitumor effects of α-interferon and γ-interferon on a murine renal cancer (Renca) in vitro and in vivo. Cancer Res. 50:5414.
2. Brunda, M. J., and R. B. Wright. 1986. Differential antiproliferative effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines. Int. J. Cancer 37:287
3. Brunda, M J., V. Sulich, and D. Bellatoni 1987. The anti-tumor effect of recombinant interferon alpha or gamma is influenced by tumor location Int J. Cancer 40:807.
4. Mule, J. J., J. C. Yang, R. Lafreniere, S. Shu, and S. A. Rosenberg 1987. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by systemic administration of high-dose recombinant interleukin-2. J. Immunol 139 285.
5. Kedar, E., and E. Klein. 1992 Cancer immunotherapy, are the results discouraging? Can they be improved? Adv. Cancer Res. 59:245.
6. Brunda, M. J., L. Luistro, and R. R. Warrier, R. B. Wright, B. R Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1994. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
7. Brunda, M J , L Luistro, J. A. Hendrzak, M. Fountoulakis, G. Garotta, and M. K. Gately. Role of Interferon-γ in mediating the antitumor efficacy of interleukin-12 J. Immunother 17:71.
8. Nastala, C. L , H D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Bunda, M. K Gately, S. F. Wolf, R D Schreiber, W. J. Storkus, and M. T. Lotze, 1994. Recombinant interleukin-12 (IL-12) administration induces tumor regression in association with interferon-gamma production. J. Immunol 153:1697.
9. Kobayashi, M , L Fitz, M. Ryan, R M. Hewick, S C Clark, S. Chan, F. Loudon, F. Sherman, B. Perussia, and G Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes J Exp. Med. 170:827.
10. Tahara, H., H J. Zeh, and W. J. Storkus III. 1994 Fibroblasts genetically engineered to secrete IL-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Res. 54:182.
11. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune response and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
12. Stern, A. S , F. J. Podlaski, J. D. Hulmes, Y. E. Pan, P. M Quinn, A. G. Wolitzky, D. L. Familletti, T. Stremlo, T. Truitt, R. Chizzonite, and M K Gately 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl Acad. Sci. USA 87:6808.
13. Wolf, S. F. P. A. Temple, M Kobayashi, D. Young, M. Dicig, L Lowe, R. Dzialo, L. Fitz, D. Ferenz, R. M. Hewick, K. Killeher, S. H. Herrmann, S. A. Clark, L Azzoni, S. H. Chan, G. Trichieri, and B Perussia 1991 Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol 146:3074
14. Gately, M K., B. Desai, A G Wolitzky, P M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizzonite, U. Gubler, and A. S Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-2 (cytotoxic lymphocyte maturation factor). J Immunol. 147.874.
15. Robertson, M J., R J. Soiffer, T. J. Wolf, C. Manley, D Donahue, S H. Young, S H. Herrmann, and J. Ritz. 1992. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175.779
16. Trinchieri, G 1994. Interleukin-12: a cytokine produced by antigen-presented cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
17. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S H Chan, M. Kobayashi, D Young, E. Nickbarg, R Chizzonite, S F. Wolf, and G. Trinchieri 1992 Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp Med. 176:1387.
18. Gubler, U., A O Chua, D S. Schoenhaut, C. M Dwyer, W. McComs, R. Motyka, N Nabavi, A. G Wolitzky, P. M. Quinn, P. C Familletti, and M. K. Gately. 1991 Coexpression of two distinct genes is required to generate secreted, bioactive cytotoxic lymphocyte maturation factor Proc. Natl. Acad. Sci. USA 181.4143.
19. Chan, S. H., B Perussia, J. W. Gupta, M. Kobayshi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri 1991. Induction of interferon production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers J. Exp. Med 173:869.
20. Wu, C., C. Demeure, M. Diniwa, M. Gately, and G Delespesse. 1993 IL-12 induces the production of IFNγ by neonatal human CD4 T cells J. Immunol. 151:1938.
21. Schoenhaut, D. S., A O Chua, A. G. Wolitzky, and P. M. Qiunn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler 1992. Cloning and expression of murine IL-12. J. Immunol. 148.3433.
22. Meltzer, M S. 1976. Tumoricidal response in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. Cell Immunol 22.176.
23. Sonouchi, K., T A Hamilton, C S Tannenbaum, R. R Tubbs, R Bukowski, and J H Finke. 1994. Chemokine gene expression in the murine renal cell carcinoma. RENCA, following treatment in vivo with interferon-alpha and interleukin-2. Am J. Pathol. 4:747.
24. Shelbani, K. and R. R. Tubbs. 1984. Enzyme immunohistochemistry: technical aspects. Semin. Diag. Pathol. 1:235.
25. Deng, W , B. Thiel, C. S. Tannenbaum, T. A. Hamilton, and D. J. Stuehr. 1993. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages J. Immunol. 151.322.
26. Sambrook, J , E F. Fritsch, and T. Maniatis. 1989 Molecular Cloning: A Laboratory Manual, 2nd ed Cold Spring Harbor Laboratory, Cold Spring Harbor.
27. Chirgwin, J. J., A. E. Przbyla, R. J. MacDonald, and W. J. Rutter 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294.
28. Hamilton, T. A., N. Bredon, Y. Ohmori, and C. S Tannenbaum. 1989. IFN-γ and IFN-β independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. J. Immunol. 142:2325.
29. Tannenbaum, C S , T. J. Koener, M M. Jansen, and T. A. Hamilton. 1988. Characterization of lipopolysaccharide-induced macrophage gene expression. J. Immunol. 140.3640.
30. Alexander, J. P., S. Kudoh, K. A. Melsop, T. A. Hamilton, M. G. Edinger, R. R. Tubbs, D. Sica, L. Tauson, E. Klein, R. M. Bukowski, and J. H. Finke. 1993. T cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce IL-2 and express IL-2 receptors. Cancer Res. 53.1380.
31. Angerer, L M , M H. Stoler, and R. C. Angerer 1987. In situ hybridization with RNA probes: an annotated recipe. In In Situ Hybridization. K. L Valentino, ed Oxford University Press, New York, p. 42.
32. Stoler, M. H. 1990. In situ hybridization. In Clinics in Laboratory Medicine, Vol. 10: Tumor Markers in Diagnostic Pathology, F. Gorstein and A. Thor, eds., W. B. Saunders, New York, p. 215.
33. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ-interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084.
34. Taub, D. D , A. R Lloyd, K Coen, J M. Wang, J. R. Ortaldo, A. Haroda, K. Matsushima, D. J Kelvin, and J. J. Oppenheim. 1993 Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T-lymphocytes and promotes T-cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
35. Narumi, S., L. M. Wyner, M. H. Stoler, C. S. Tannenbaum, and T. A. Hamilton. 1992. Tissue specific expression of murine IP-10 during intravenous treatment with inflammatory stimuli. J. Leukocyte Biol. 52.27
36. Masson, D , and J. Tschopp. 1987. A family of serine esterases in lytic granules of cytolytic T-lymphocytes. Cell 49.679.
37. Podack, E R, H. Hengartner, and M. G. Lichtenheld. 1991. A central role of perform in cytolysis. Annu. Rev. Immunol 9:129.
38. - cells. J. Immunol. 148 3354.
39. Liu, C. C., S V Joag, B. S. Kuon, and J. D Young 1990 Induction of perforin and serine esterases in a murine cytotoxic T-lymphocyte clone. J Immunol. 144: 1196.
40. Cesano, A , S. Visonneau, S C Clark, and D Santoli. 1993. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J. Immunol 151.2943.
41. Salcedo, T. W., L. Azzoni, S. F Wolf, and B Perussini. 1993 Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol. 151:2511
42. Berke, G., D Rosen, and D. Ronen. 1993. Mechanisms of lymphocyte-mediated cytolysis: functional cytolytic T-cells lacking perform and granzymes. Immunology 78.105
43. Lowin, B , F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T-lymphocyte and natural killer cell mediated cytotoxicity. Proc. Natl. Acad Sci. USA 91:11571.
44. Heusel, J. W., R. L Wesselschmidt, S. Shresta, J H Russell, and T. J. Ley. 1994 Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
45. Luster, A D., and P. Leder. 1993. IP-10, a C-X-C chemokine, elicits a potent thymus-dependent anti-tumor response in vivo. J. Exp. Med. 178.1057.
46. Voest, E. E , B. M. Kenyon, M S. O'Reilly, G. Truitt, R. J. D'Amato, and J. Folkman. 1995. Inhibition of angiogenesis in vivo by Interleukin 12 J. Natl Cancer Inst. 87:581.
47. Angiolillo, A L , C Sgadari, D. D. Taub, F Liao, J. M Farber, S Maheshwari, H Kleinman, G. H Reaman, and G. Tosato 1995 Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155.
48. Luster, A. D , S. M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation J. Exp. Med. 182:219
49. Strieter, R M., S L Kunkel, D. A. Arenberg, M D. Burdick, and P. J. Polverini. 1995. Interferonγ-inducible protein-10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis Biochem. Biophys. Res Commun. 210:51.